Edition:
India

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671.SS)

600671.SS on Shanghai Stock Exchange

16.10CNY
12:29pm IST
Change (% chg)

¥0.09 (+0.56%)
Prev Close
¥16.01
Open
¥15.81
Day's High
¥16.17
Day's Low
¥15.62
Volume
517,048
Avg. Vol
1,157,427
52-wk High
¥29.60
52-wk Low
¥15.15

Chart for

About

Hangzhou TianMuShan Pharmaceutical Enterprise Co., Ltd is a China based company principally engaged in the research and development, production and sales of pharmaceuticals and related health products. The Company is mainly engaged in the manufacture of chemical drug substances, processing of Chinese herbal pieces as well as the... (more)
No analyst recommendations are available for .

Overall

Beta: 0.56
Market Cap(Mil.): ¥3,454.87
Shares Outstanding(Mil.): 121.78
Dividend: --
Yield (%): --

Financials

  600671.SS Industry Sector
P/E (TTM): 1,541.01 30.95 32.74
EPS (TTM): 0.02 -- --
ROI: 3.12 14.84 14.38
ROE: 4.45 16.34 16.08

BRIEF-Hangzhou Tianmushan Pharmaceutical Enterprise receives GMP certificate

Feb 13 Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd :

13 Feb 2018

BRIEF-Hangzhou Tianmushan Pharmaceutical Enterprise sees FY 2017 net profit up 1,872 pct to 2,364 pct

Feb 1Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd :

01 Feb 2018

BRIEF-Hangzhou TianMuShan Pharmaceutical Enterprise unit obtains high-tech enterprise recognition again

Jan 11 Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

11 Jan 2018

BRIEF-Hangzhou Tianmushan Pharmaceutical Scraps Asset Restructuring Plan

Jan 2 Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd:

02 Jan 2018

BRIEF-Hangzhou Tianmushan Pharma Halts Acquisition Plan As Related Parties Fail To Reach Agreement

Dec 29 Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd:

29 Dec 2017

REFILE-BRIEF-Hangzhou Tianmushan Pharmaceutical Enterprise's Shares To Halt Trade From Dec 26

Dec 25 Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd:

25 Dec 2017

Earnings vs. Estimates